You are here

Article Text

Article menu

Download PDFPDF

Diagnostics
2022-RA-752-ESGO The efficacy of HPV test for cervical cancer screening
Free
  1. Heekyoung Song1,
  2. Jiyun Hong2 and
  3. Soo Young Hur3
  1. 1Department of Obstetrics and Gynecology, Incheon St. Mary’s Hospital, College of Medicine, the Catholic University of Korea, Incheon, Korea, Republic of
  2. 2Department of Obstetrics and Gynecology, St. Vincent Hospital, College of Medicine, the Catholic University of Korea, Suwon-si, Gyeonggi-do, Korea, Republic of
  3. 3Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, the Catholic University of Korea, Seoul, Korea, Republic of

Abstract

Introduction/Background About 3,218 new cervical cancer cases are diagnosed annually (estimations for 2020) and the third most common female cancer in women aged 15 to 44 years in Korea. For more than a half century, cervical cytology testing has been the foundation for screening for cervical cancer and the burden of this disease. Cervical cancer is now recognized to be caused by persistent infection of HPV which develop primarily as precancerous lesions and then progress to invasive cancer.

Methodology The patients were selected in Korean HPV Cohort study and followed-up at every 6-month intervals. Only patients who had been tissue biopsy were included this study. We evaluated the results of cytology, HPV DNA test, and pathologic result of the included patients were compared with each other to check up efficacy of diagnosis between cytology and HPV DNA testing. This abstract was preliminary result.

Results The patients were selected in Korean HPV Cohort study and followed-up at every 6-month intervals. Only patients who had been tissue biopsy were included this study. We evaluated the results of cytology, HPV DNA test, and pathologic result of the included patients were compared with each other to check up efficacy of diagnosis between cytology and HPV DNA testing. This abstract was preliminary result.

Conclusion The use of HPV testing improved sensitivity better than liquid-based cytology with or without colposcopy-based biopsy. It recommends an HPV DNA based test as the preferred method, rather than cytology, currently the most commonly used methods to detect pre-cancer lesions.

https://doi.org/10.1136/ijgc-2022-ESGO.158

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.